# Cataract Surgery Device Market

> Cataract Surgery Devices Market Research Report Information By Device Type (Intraocular lens (IOL), Ophthalmic Viscoelastic Device (OVD), Phacoemulsification Equipment and Femtosecond Laser Equipment), By End-Users (Ophthalmology Centers, Hospitals and Clinics), and By Region (North America, Europe, Asia-Pacific, And Rest Of The World) - Growth & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 5.22%
- **2024:** $ 9.1 Billion
- **2025:** $ 9.58 Billion
- **2035:** $ 15.93 Billion
- **Key Players:** Key players include Alcon Inc. (U.S.), Abbott Laboratories (U.S.), Carl Zeiss Meditech AG (Germany), Essilor International S.A. (France), Bausch & Lomb Inc. (U.S.), and NIDEK Co. Ltd. (Japan).

**Report ID:** MRFR/MED/1579-HCR · **Pages:** 80 · **Author:** Satyendra Maurya & Rahul Gotadki · **Last Updated:** June 26, 2026

**URL:** https://www.marketresearchfuture.com/reports/cataract-surgery-device-market-2115

---

## Market Summary

As per Market Research Future Analysis, the Global Cataract Surgery Devices Market was valued at USD 9.10 billion in 2024 and is projected to reach USD 15.93 billion by 2035, growing at a CAGR of 5.22% from 2025 to 2035. The increasing prevalence of ocular illnesses, particularly cataracts, is a significant driver of market growth. In 2022, approximately 30 million cataract surgeries were performed globally, with over 10 million surgeries conducted annually. The market is also influenced by advancements in laser technology and the availability of high-quality intraocular lens (IOL) implants, which enhance surgical outcomes and patient satisfaction.

## Market Drivers

### Increasing Aging Population

The Global Cataract Surgery Devices Market Industry is experiencing growth driven by the increasing aging population. As individuals age, the prevalence of cataracts rises significantly, necessitating surgical intervention. By 2024, the market is projected to reach 9.1 USD Billion, reflecting the growing demand for cataract surgeries. The World Health Organization indicates that cataracts are the leading cause of blindness among older adults, with an estimated 20 million people affected globally. This demographic shift suggests a sustained increase in the need for advanced surgical devices and techniques, thereby propelling the market forward.

## Future Outlook

The Cataract Surgery Devices Market is projected to grow at a 5.20% CAGR from 2025 to 2035, driven by technological advancements, increasing aging population, and rising healthcare expenditure.

**New opportunities:**

- Invest in AI-driven surgical devices to enhance precision and patient outcomes. Develop cost-effective cataract solutions for emerging markets to expand customer base. Leverage telemedicine platforms for pre- and post-operative care to improve patient engagement.

By 2035, the Cataract Surgery Devices Market is expected to achieve substantial growth, reflecting advancements and increased accessibility.

## Segment Insights

### Cataract Surgery Devices Device Type Insights

The  Cataract Surgery Devices Market segmentation, based on device type, includes Intraocular lens (IOL), Ophthalmic Viscoelastic Device (OVD), Phacoemulsification Equipment and Femtosecond Laser Equipment. The intraocular lens (IOL) segment held the majority share in 2023 in the  Cataract Surgery Devices Market data. Medical devices are utilised during intraocular lens (IOL) cataract surgery to remove cataracts from the eyes. IOLs are used to correct eyesight by being placed into the eye through a tiny incision. IOLs can be made of artificial materials or can be made by physically removing the normal lens and substituting it with an IOL.

### Cataract Surgery Devices End-Users Insights

The  Cataract Surgery Devices Market data, based on end-users, includes [Ophthalmology Diagnostic](https://www.marketresearchfuture.com/reports/ophthalmology-diagnostic-market-42283) Centers, Hospitals and Clinics. The hospitals segment dominated the cataract surgery devices market revenue for cataract surgery devices in 2022 and is projected to be the faster-growing segment during the forecast period, 2024-2032. Throughout the projection period, the hospitals segment is expected to be driven by an increase in the number of cataract operations performed in hospitals across all geographical regions.

The adoption of cataract surgery devices in hospitals is likely to be boosted by a number of factors, including changing healthcare infrastructure in developing nations and an increase in the number of cutting-edge healthcare facilities, which will ultimately speed up the growth of the hospital segment in the Cataract Surgery Devices Market over time.

Figure 2:  Cataract Surgery Devices Market, by End-Users, 2023 & 2032 (USD Billion)

## Regional Market Share Analysis

By region, the study provides the market insights for cataract surgery devices into North America, Europe, Asia-Pacific and Rest of the World. North America cataract surgery devices market accounted for USD 3.9 billion in 2023 with a share of around 45.80% and is expected to exhibit a significant CAGR growth during the study period. This is explained by the substantial presence of major market participants in the United States as well as the significant volume of cataract operations.

The main drivers propelling market expansion in the region are the advantageous reimbursement policies of insurance companies and rising awareness regarding ocular illnesses.

Further, the major countries studied in the market report for cataract surgery devices are: The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Asia Pacific cataract surgery devices market accounts for the second-largest market share. One of the main reasons Asia Pacific has dominated the market for cataract surgery devices is the higher frequency of cataract disorders and subsequent surgical intervention. The market in the region will be supported by favorable reimbursement policies and rising intraocular lens penetration in nations like Japan, China, and India. Moreover, China cataract surgery devices market held the largest market share, and the India cataract surgery devices market was the fastest growing market in the region.

Europe cataract surgery devices Market is expected to grow at the fastest CAGR from 2024 to 2032 due to the economy's rapid improvement and a sizable population base with unmet demand for accessible [eye care](../../../reports/eye-care-supplements-market-4457) services. Additionally, the possibilities for regional growth are aided by the expanding medical tourism sector and an increase in international investments. Further, the UK cataract surgery devices market held the largest market share, and the Germany cataract surgery devices market was the fastest growing market in the region.

## Competitive Benchmarking

Major market players are spending a lot of money on R&D to increase their product lines, which will help the cataract surgery devices market grow even more. Market participants are also taking a range of strategic initiatives to grow their worldwide footprint, with key market developments such as new product launches, contractual agreements, mergers and acquisitions, increased investments, and collaboration with other organizations. Competitors in the cataract surgery devices industry must offer cost-effective items to expand and survive in an increasingly competitive and rising market environment.
One of the primary business strategies adopted by manufacturers in the global cataract surgery devices industry to benefit clients and expand the market sector is to manufacture locally to reduce operating costs. In recent years, cataract surgery devices industry has provided medicine with some of the most significant benefits. The cataract surgery devices market major player such as Alcon Inc. (U.S), Abbott Laboratories (U.S.), Carl Zeiss Meditech AG (Germany), Essilor International S.A. (France), Opcon Corporation (Japan), Allergan Inc. (U.S.), Bausch & Lomb Inc. (U.S.), NIDEK Co. Ltd. (Japan) and STAAR Surgical Company (U.S.).
With its headquarters in Geneva, Switzerland, and its incorporation in Fribourg, Switzerland, Alcon is an American-Swiss medical firm that specialises in eye care products. The Alcon part of the corporation was founded in Fort Worth, Texas, where Alcon was first established as a US company.
In January in India, Alcon introduced the AcrySof IQ Vivity IOL, a presbyopia-correcting intraocular lens (PC-IOL) with wavefront-shaping technology for patients having cataract surgery.
Carl Zeiss created Carl Zeiss AG, often known as ZEISS, an optical and optoelectronics business in Jena, Germany, in 1846. He helped lay the groundwork for the current multinational corporation with Otto Schott and Ernst Abbe.
In April Carl Zeiss Meditec purchased the surgical tool manufacturers Kogent Surgical and Katalyst Surgical. The acquisition served to grow the businesses and support the delivery of surgical treatment options.

## Recent News & Developments

**July 2021:**A phacoemulsification (phaco) system was released by Johnson & Johnson (J&J) Vision globally and made accessible in several nations. This technique enables surgeons to merge and remove the internal lens of the eye when it gets hazy due to cataracts with greater efficiency and comfort during surgery.

**October 2020:**HOYA Surgical Optics announced the release of CLEARlog, an app created by the business that enables surgeons to swiftly record and analyse their cataracts. It is intended to be a time- and money-efficient alternative for surgeons who want to perform a thorough multifactorial study of their results.

## Report Scope

| Attribute/Metric | Details |
| --- | --- |
| Market Size 2024 | USD 9.1 billion |
| Market Size 2035 | 15.93 (Value (USD Billion)) |
| Compound Annual Growth Rate (CAGR) | 5.22% (2025 - 2035) |
| Base Year | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2018 - 2021 |
| Market Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Device Type, End-Users and Region |
| Geographies Covered | North America, Europe, Asia Pacific, and Rest of the World |
| Countries Covered | The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
| Key Companies Profiled | Alcon Inc. (U.S), Abbott Laboratories (U.S.), Carl Zeiss Meditech AG (Germany), Essilor International S.A. (France), Opcon Corporation (Japan), Allergan Inc. (U.S.) |
| Key Market Opportunities | New product launches and R&D Amongst major key Players |
| Key Market Dynamics | Increasing prevalence of cataract surgery  Increase in the aging population |
| Market Size 2025 | 9.58 (Value (USD Billion)) |

## Frequently Asked Questions

**Q: What is the projected growth of the Cataract Surgery Devices market?**
A: The Cataract Surgery Devices market is the expected increase in total market value of 15.93 USD billion over a defined forecast period 2025–2035. It is driven by factors such as demand trends, technological advances, regulatory changes, and geographic expansion.

**Q: What is the size of the Cataract Surgery Devices market?**
A: Cataract Surgery Devices market size was valued at approximately 9.1 billion USD in 2024. This figure will reach 15.93 billion USD covering all regions (America, Europe, Asia, MEA and ROW), focusing its segments / services / distribution channels till 2035.

**Q: What is the CAGR of the Cataract Surgery Devices market?**
A: Cataract Surgery Devices market is expected to grow at a CAGR of 5.22% between 2025 and 2035.

**Q: How much will the Cataract Surgery Devices market be worth by 2035?**
A: Cataract Surgery Devices market is expected to be worth of 15.93 billion USD, reflecting growth driven by usage, technology and global demands by the end of 2035.

**Q: How will the Cataract Surgery Devices market perform over the next 10 years?**
A: Over the next 10 years the Cataract Surgery Devices market is expected to shift from usd billion 9.1 to 15.93 billion USD, led by adoption of advanced tech, demographic trends, regulatory approvals, with potential headwinds from 2025 to 2035.

**Q: Which region held the largest market share in the cataract surgery devices market?**
A: North America had the largest share in the global market for cataract surgery devices.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/cataract-surgery-device-market-2115*
